Avalo Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 02/17/2026 | 1.36 M | $24.61 M | 0.00% | 9.68% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 1.24 M | $22.43 M | 0.00% | 8.82% |
| ORBIMED ADVISORS LLC | 02/17/2026 | 1.19 M | $21.56 M | -12.01% | 8.48% |
| AFFINITY ASSET ADVISORS, LLC | 02/13/2026 | 1.05 M | $19.09 M | 4.46% | 7.51% |
| CALIGAN PARTNERS LP | 02/17/2026 | 881.53 K | $16.01 M | 5.78% | 6.30% |
| VANGUARD GROUP INC | 01/29/2026 | 804.08 K | $14.60 M | 16.09% | 5.74% |
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 662.97 K | $12.04 M | 0.00% | 4.74% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 659.98 K | $11.99 M | 380.23% | 4.71% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 627.50 K | $11.40 M | -40.46% | 4.48% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 621.35 K | $11.28 M | 2.56% | 4.44% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 550.00 K | $9.99 M | 112.54% | 3.93% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/12/2026 | 524.44 K | $9.52 M | -27.25% | 3.75% |
| MARSHALL WACE, LLP | 02/13/2026 | 507.55 K | $9.22 M | 806.19% | 3.63% |
| COMMODORE CAPITAL LP | 02/17/2026 | 483.00 K | $8.77 M | 0.00% | 3.45% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/17/2026 | 483.00 K | $8.77 M | 0.00% | 3.45% |
| UBS GROUP AG | 01/29/2026 | 477.82 K | $8.68 M | 956.93% | 3.41% |
| JENNISON ASSOCIATES LLC | 01/30/2026 | 475.63 K | $8.64 M | 100.00% | 3.40% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 441.98 K | $8.03 M | 100.00% | 3.16% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 439.31 K | $7.98 M | -46.26% | 3.14% |
| CITADEL ADVISORS LLC | 02/17/2026 | 419.49 K | $7.62 M | -12.91% | 3.00% |
| PATIENT SQUARE CAPITAL LP | 02/12/2026 | 311.97 K | $5.67 M | 211.97% | 2.23% |
| BLACKROCK, INC. | 02/12/2026 | 289.57 K | $5.26 M | 87.73% | 2.07% |
| BOXER CAPITAL MANAGEMENT, LLC | 02/17/2026 | 275.00 K | $4.99 M | 120.00% | 1.96% |
| MORGAN STANLEY | 02/13/2026 | 264.91 K | $4.81 M | 2,648,970.00% | 1.89% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/13/2026 | 263.64 K | $4.79 M | 0.00% | 1.88% |
| FMR LLC | 02/17/2026 | 220.30 K | $4.00 M | 100.00% | 1.57% |
| AMERIPRISE FINANCIAL INC | 02/17/2026 | 217.97 K | $3.96 M | 2.06% | 1.56% |
| JAIN GLOBAL LLC | 02/17/2026 | 217.29 K | $3.95 M | 100.00% | 1.55% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 210.99 K | $3.83 M | 345.15% | 1.51% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/17/2026 | 202.13 K | $3.67 M | -11.46% | 1.44% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 197.75 K | $3.59 M | 3,954,840.00% | 1.41% |
| SUMMITTX CAPITAL, L.P. | 02/17/2026 | 195.87 K | $3.56 M | 100.00% | 1.40% |
| NAN FUNG TRINITY (HK) LTD | 02/04/2026 | 189.00 K | $3.43 M | 100.00% | 1.35% |
| JANE STREET GROUP, LLC | 02/12/2026 | 178.86 K | $3.25 M | 100.00% | 1.28% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 166.15 K | $3.02 M | 59.47% | 1.19% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/17/2026 | 153.31 K | $2.78 M | -18.49% | 1.10% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 150.00 K | $2.72 M | 100.00% | 1.07% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 150.00 K | $2.72 M | 100.00% | 1.07% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 148.24 K | $2.69 M | 201.04% | 1.06% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 139.67 K | $2.54 M | 0.00% | 1.00% |
| STEMPOINT CAPITAL LP | 02/17/2026 | 135.55 K | $2.46 M | 100.00% | 0.97% |
| MOODY ALDRICH PARTNERS LLC | 01/30/2026 | 133.23 K | $2.42 M | 100.00% | 0.95% |
| 02/17/2026 | 130.00 K | $2.36 M | 100.00% | 0.93% | |
| GREAT POINT PARTNERS LLC | 02/17/2026 | 124.67 K | $2.26 M | 100.00% | 0.89% |
| BARCLAYS PLC | 02/13/2026 | 105.81 K | $1.92 M | 1,032.18% | 0.76% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 100.00 K | $1.82 M | 100.00% | 0.71% |
| HIGHVISTA STRATEGIES LLC | 02/17/2026 | 95.63 K | $1.74 M | 244.27% | 0.68% |
| ABRDN PLC | 01/16/2026 | 95.43 K | $1.73 M | 31.08% | 0.68% |
| FRED ALGER MANAGEMENT, LLC | 02/17/2026 | 80.09 K | $1.45 M | 100.00% | 0.57% |
| STATE STREET CORP | 02/13/2026 | 79.25 K | $1.44 M | 74.36% | 0.57% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Avalo Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 111 institutional investors and hedge funds held shares of Avalo Therapeutics Inc. The most heavily invested institutionals were:
UBS Group AG: 1.14 M
JENNISON ASSOCIATES LLC: 470,775
BNP PARIBAS ARBITRAGE, SNC: 422,781
NAN FUNG TRINITY (HK) Ltd: 189,000
JANE STREET GROUP, LLC: 173,320
abrdn plc: 171,679
142.03% of Avalo Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 20.95 M shares in the last 24 months. This purchase volume represents approximately $362.56 M in transactions.